CSF2 and Sepsis: GM-CSF, a myelopoietic growth factor, has been proposed for the treatment of sepsis (75, 76) as GM-CSF is a strong activator of phagocytosis and promotes phagocyte infiltration and expansion in inflamed tissues (77).